Co-founder & CEO
Nathan was previously co-founder and CEO of PharmaSecure where he helped accelerate adoption of serialization as the standard in global pharmaceutical supply chain. Nathan is a graduate of Dartmouth College.
Co-founder & Customer Development
Richard was previously Director General of EFPIA and worked in regulatory affairs at Roche and Novartis. He has also served as Director of EU Regulatory Strategy at Roche and Director-General of LIF.
Julia serves on the Board of Directors of PharmaCCX. She is currently COO at Tempest. She has been a commercial leader at Ginger.io, Beacon Health Options, Institute on Aging, and McKinsey. Julia is a graduate of Stanford GSB and Dartmouth College.
Chief Operating Officer
Prior to PharmaCCX Peter was Chief of Staff at Formlabs and held several roles at Alarm.com (ALRM) including Director of Program Management and rotations in Strategic Planning, Product Management, Supply Chain, and Finance. Peter is a graduate of Colby College and Thayer School of Engineering at Dartmouth College.
Chief Technology officer
Before joining PharmaCCX, Armen served in design and development roles at Farallon Capital Management, LifeYield and Charles River where he led the development of Fixed Income Execution Platform as part of the Charles River IMS. He holds an M.S. in Computer Science from Armenian State Polytechnic Institute.
Barath joined Accel in 2012 and serves on the PharmaCCX Board of Directors. He has been in the healthcare domain for over a decade, having previously been a senior consultant at Frost & Sullivan covering healthcare and life sciences. Barath has a bachelor’s degree in Pharmacy from BITS, Pilani and an MBA from Carnegie Mellon University.
An inventor and a leading authority on risk and financial markets, Marc's research forms the foundation of our approach. Marc has served in mission-critical technology and investment modeling roles at Morgan Stanley, Van Eck Global, and Structured Portfolio Management.
Former MD of Alcon and Warner-Lambert Switzerland, Walter leads VIPS (Swiss Pharma Association) as well as an organization that provides standards for unique identification of products and services.
Patrick was an ICU physician who left medical practice to join The Boston Consulting Group. He was recruited to build and lead the IMS Health consulting business in Switzerland and then launched his own practice consulting with the pharmaceutical industry on a variety of strategic areas, including pricing.